Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03749031 · ClinicalTrials.gov registry record · NA
Effects of Beverages Containing Orange or Apple Pomace on Digestive Health in Adults
A NA study, sponsored by PepsiCo Global R&D.
- Completed
- Registry status
- NA
- Development phase
- 90
- Enrollment target
NCT03749031: Completed NA study, sponsored by PepsiCo Global R&D.
NCT03749031 is a NA study that has completed, run by PepsiCo Global R&D. The registered enrollment target is 90 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03749031, a NA study, has completed, sponsored by PepsiCo Global R&D.
- COMPLETED
- Registry status
- NA
- Development phase
- 90 participants
- Enrollment target
Study Summary
This is a randomized crossover intervention designed to evaluate effects of daily intake of beverages containing orange or apple Pomace on gastrointestinal function as measured by stool frequency. Additional outcomes will include aspects of digestive health and self-reported GI symptoms and dietary intake as well as analysis of gut microbiota.
Primary Outcome
Bowel habits daily diary as weekly averages. Fewer days with no stool, and higher number of stools per week would be better.
Interventions
- OTHER Orange juice + Orange Pomace
- OTHER Orange Juice
- OTHER Apple Juice and Apple Pomace
- OTHER Apple Juice
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 90 participants |
| Start Date | 2018-10-15 |
| Est. Completion | 2019-08-30 |
| Phase | NA |
What the finished NCT03749031 record still lists
NCT03749031 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 90 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower).
The record links to 0 conditions, and to 4 interventions - of which Orange juice + Orange Pomace is the first listed.
NCT03749031 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03749031 about?
NCT03749031 is a clinical study titled "Effects of Beverages Containing Orange or Apple Pomace on Digestive Health in Adults". This is a randomized crossover intervention designed to evaluate effects of daily intake of beverages containing orange or apple Pomace on gastrointestinal function as measured by stool frequency. Additional outcomes will include aspects of digestive health and self-reported GI symptoms and dietary ...
What is the current status of trial NCT03749031?
This trial is currently completed. It is a NA study. The enrollment target is 90 participants. The study started on 2018-10-15. Estimated completion is 2019-08-30.
What interventions are being tested in trial NCT03749031?
The interventions under investigation include: Orange juice + Orange Pomace (OTHER), Orange Juice (OTHER), Apple Juice and Apple Pomace (OTHER), Apple Juice (OTHER).
Who is sponsoring clinical trial NCT03749031?
This trial is sponsored by PepsiCo Global R&D, which has 47 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03749031's enrollment target sits among peer trials
90 941st of 2000 higher than 1,029 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02521311 · 90 participants · Phase 2
Assessment of Clemastine Fumarate as a Remyelinating Agent in Acute Optic Neuritis (ReCOVER)
- NCT02939573 · 90 participants · Phase 2
A Randomized Multicenter Study for Isolated Skin Vasculitis
- NCT03128879 · 90 participants · Phase 2
Venetoclax With Ibrutinib or Acalabrutinib in Pts. With High-risk CLL
- NCT03184038 · 90 participants · NA
Neurocognition in Patients With Multiple Brain Metastases Treated With Radiosurgery
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI